Logo Image
News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions PodcastShorts
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers
Event Calendar

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Event Calendar
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Bob Todd

Advertisement

Bob Todd is vice-president of Process Development at KBI BioPharma

Articles by Bob Todd

Using Simulation to Address Capacity Limitations

ByJoseph F. Pekny,Spencer Miller,Stephen Hunt,John Robinson,Laurence T. Baxter,Bob Todd
September 2nd 2017

Modeling tools help process engineers optimize a biopharmaceutical facility’s capacity.

Advertisement

Latest Updated Articles

  • Using Simulation to Address Capacity Limitations
    Using Simulation to Address Capacity Limitations

    September 2nd 2017



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

FDA Activity Round Up – July 2026

2

Midyear 2026 Check-In: Agentic AI Cuts Deviation Investigations by 50%

3

Can Governance-by-Design Make AI Compliant in Pharma? (Part II)

4

From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026

5

Brent Wilhelm on Why Drug Shortages Persist Despite Available Inventory

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us